Screening for Th17-Dependent Pneumococcal Vaccine Antigens: Comparison of Murine and Human Cellular Immune Responses

Infection and Immunity
Ying-Jie LuRichard Malley

Abstract

Conjugate vaccines against Streptococcus pneumoniae have significantly reduced the incidence of diseases caused by the serotypes included in those vaccines; however, there is still a need for vaccines that confer serotype-independent protection. In the current study, we have constructed a library of conserved surface proteins from S. pneumoniae and have screened for IL-17A and IL-22 production in human immune cells obtained from adenoidal/tonsillar tissues of children and IL-17A production in splenocytes from mice that had been immunized with a killed whole-cell vaccine or previously exposed to pneumococcus. A positive correlation was found between the rankings of proteins from human IL-17A and IL-22 screens, but not between those from human and mouse screens. All proteins were tested for protection against colonization, and we identified protective antigens that are IL-17A dependent. We found that the likelihood of finding a protective antigen is significantly higher for groups of proteins ranked in the top 50% of all three screens than for groups of proteins ranked in the bottom 50% of all three. The results thus confirmed the value of such screens for identifying Th17 antigens. Further, these experiments have evaluated and c...Continue Reading

References

Feb 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Javier Mestas, Christopher C W Hughes
Mar 23, 2005·Proceedings of the National Academy of Sciences of the United States of America·Richard MalleyMarc Lipsitch
Jul 2, 2008·The Journal of Experimental Medicine·Cindy S MaMatthew C Cook
Sep 20, 2008·PLoS Pathogens·Ying-Jie LuRichard Malley
Jun 3, 2009·The Journal of Experimental Medicine·Yoshiyuki MinegishiHajime Karasuyama
Jun 11, 2009·The Journal of Clinical Investigation·Zhe ZhangJeffrey N Weiser
Dec 2, 2009·The Journal of Infectious Diseases·Tamara PilishviliUNKNOWN Active Bacterial Core Surveillance/Emerging Infections Program Network
Feb 16, 2011·Cell Host & Microbe·Kristin L MoffittRichard Malley
Jul 31, 2013·Critical Reviews in Microbiology·Michelle DarrieuxLuciana Cezar de Cerqueira Leite
Nov 5, 2015·Human Vaccines & Immunotherapeutics·Kristin Moffitt, Richard Malley
Feb 6, 2018·Human Vaccines & Immunotherapeutics·Leen MoensXavier Bossuyt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.